This inventor holds 3 USPTO granted patents. Top assignees: Merck + Co., Inc., Other. Active years: 1999-2003.
Location History:
- Brossard, CA (1999 - 2003)
- Quebec, CA (2003)
Company Filing History:
1 out of 4,770 
2 out of 834,411 Years Active: 1999-2003
Title: Jilly Evans - Innovator in Colonic Adenoma Treatment
Introduction
Jilly Evans is a notable inventor based in Brossard, CA. She has made significant contributions to the field of medical treatments, particularly in the area of colonic adenomas. With a total of 3 patents to her name, her work has the potential to impact many lives.
Latest Patents
One of her latest patents is a method of treating colonic adenomas. This invention is directed to a method of retarding or preventing the transformation of a colonic adenoma to a colonic adenocarcinoma. It involves the administration to a patient with familial adenomatous polyposis (FAP) or a patient with one or more adenomas a non-toxic therapeutically effective amount of NSAID. This amount is effective to inhibit the PGHS-2 in the adenoma. The preferred method comprises the administration of a specific PGHS-2 inhibiting agent as defined in her patent.
Career Highlights
Throughout her career, Jilly has worked with prominent companies, including Merck & Co., Inc. Her innovative approaches and dedication to research have established her as a respected figure in her field.
Collaborations
Jilly has collaborated with several professionals, including Stacia Kargman and Thomas J. Simon. These collaborations have further enriched her work and contributed to her success as an inventor.
Conclusion
Jilly Evans is a pioneering inventor whose work in treating colonic adenomas showcases her commitment to advancing medical science. Her patents reflect her innovative spirit and dedication to improving patient outcomes.